BidaskClub upgraded shares of Hologic (NASDAQ:HOLX) from a hold rating to a buy rating in a research report released on Saturday, BidAskClub reports.

Several other brokerages also recently commented on HOLX. Zacks Investment Research raised shares of Hudson Technologies from a sell rating to a hold rating in a research note on Wednesday, May 29th. BTIG Research raised their price target on shares of Yum! Brands to $114.00 and gave the company a buy rating in a research note on Thursday, May 2nd. TheStreet downgraded shares of ZTO Express (Cayman) from a b+ rating to a c rating in a research note on Wednesday, May 1st. Needham & Company LLC dropped their price target on shares of to $10.00 and set a buy rating for the company in a research note on Wednesday, July 10th. Finally, ValuEngine raised shares of China Southern Airlines from a sell rating to a hold rating in a research note on Tuesday, June 11th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company. Hologic has an average rating of Hold and an average price target of $45.02.

NASDAQ:HOLX traded up $0.13 on Friday, hitting $49.49. The company had a trading volume of 1,068,613 shares, compared to its average volume of 1,984,292. The stock has a market cap of $13.27 billion, a PE ratio of 22.19, a price-to-earnings-growth ratio of 2.29 and a beta of 0.72. The company has a quick ratio of 1.02, a current ratio of 1.45 and a debt-to-equity ratio of 1.31. The company’s 50 day moving average price is $48.05. Hologic has a 52 week low of $37.47 and a 52 week high of $49.78.

Hologic (NASDAQ:HOLX) last issued its quarterly earnings data on Wednesday, May 1st. The medical equipment provider reported $0.58 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.57 by $0.01. The business had revenue of $818.40 million during the quarter, compared to the consensus estimate of $806.99 million. Hologic had a negative net margin of 0.32% and a positive return on equity of 26.73%. The firm’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.53 EPS. As a group, equities analysts expect that Hologic will post 2.42 earnings per share for the current fiscal year.

In other news, insider Peter J. Valenti III sold 4,545 shares of the firm’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $44.07, for a total transaction of $200,298.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.90% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Northpointe Capital LLC acquired a new stake in shares of Hologic during the second quarter worth $1,993,000. McGuire Investment Group LLC increased its position in shares of Hologic by 20.6% during the second quarter. McGuire Investment Group LLC now owns 96,190 shares of the medical equipment provider’s stock worth $4,619,000 after buying an additional 16,446 shares during the period. Strs Ohio increased its position in shares of Hologic by 51.0% during the second quarter. Strs Ohio now owns 57,394 shares of the medical equipment provider’s stock worth $2,756,000 after buying an additional 19,378 shares during the period. Hartford Investment Management Co. increased its position in shares of Hologic by 1.0% during the second quarter. Hartford Investment Management Co. now owns 29,736 shares of the medical equipment provider’s stock worth $1,428,000 after buying an additional 291 shares during the period. Finally, Arizona State Retirement System increased its position in shares of Hologic by 23.4% during the second quarter. Arizona State Retirement System now owns 159,375 shares of the medical equipment provider’s stock worth $7,653,000 after buying an additional 30,269 shares during the period. Institutional investors own 96.38% of the company’s stock.

About Hologic

Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

Featured Story: Index Funds

Analyst Recommendations for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.